- Home
- PRME vs MBUU Comparison
PRME vs MBUU Comparison
Compare PRME & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- MBUU
- Stock Information
- Founded
- PRME 2019
- MBUU 1982
- Country
- PRME United States
- MBUU United States
- Employees
- PRME N/A
- MBUU N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- MBUU Marine Transportation
- Sector
- PRME Health Care
- MBUU Industrials
- Exchange
- PRME Nasdaq
- MBUU Nasdaq
- Market Cap
- PRME 601.1M
- MBUU 654.5M
- IPO Year
- PRME 2022
- MBUU 2014
- Fundamental
- Price
- PRME $3.69
- MBUU $26.70
- Analyst Decision
- PRME Buy
- MBUU Hold
- Analyst Count
- PRME 6
- MBUU 8
- Target Price
- PRME $9.31
- MBUU $33.57
- AVG Volume (30 Days)
- PRME 4.3M
- MBUU 260.9K
- Earning Date
- PRME 11-07-2025
- MBUU 10-30-2025
- Dividend Yield
- PRME N/A
- MBUU N/A
- EPS Growth
- PRME N/A
- MBUU N/A
- EPS
- PRME N/A
- MBUU 0.98
- Revenue
- PRME $5,977,000.00
- MBUU $830,714,000.00
- Revenue This Year
- PRME $179.58
- MBUU N/A
- Revenue Next Year
- PRME N/A
- MBUU $7.47
- P/E Ratio
- PRME N/A
- MBUU $27.37
- Revenue Growth
- PRME 647.13
- MBUU 11.54
- 52 Week Low
- PRME $1.11
- MBUU $24.07
- 52 Week High
- PRME $6.94
- MBUU $46.81
- Technical
- Relative Strength Index (RSI)
- PRME 41.47
- MBUU 45.26
- Support Level
- PRME $3.17
- MBUU $24.07
- Resistance Level
- PRME $4.04
- MBUU $26.86
- Average True Range (ATR)
- PRME 0.40
- MBUU 1.17
- MACD
- PRME -0.00
- MBUU 0.02
- Stochastic Oscillator
- PRME 35.74
- MBUU 64.89
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About MBUU Malibu Boats Inc.
Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is a top manufacturer of performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the US in the 24- to 29-foot segment, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a top seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories, and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.